Enterra Medical, an emerging, U.S. based medical device company, markets a novel, implantable neurostimulator focused on the treatment of nausea and vomiting secondary to Gastroparesis. The Enterra Medical business was launched as an independent company in January of 2022, spinning out of Medtronic.